Please find attached Intimation regarding Schedule of Analyst/ Institutional Investors Meet

October 22, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Sub.: Intimation of Schedule of Analyst / Institutional Investors’ Meet Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulation 30 & 51 of the Listing Regulations, we wish to inform you that the Company will be hosting an “Analyst / Institutional Investors’ Meet” as per the details set out below: Date Type Location Zoom Link October 27, 2026 In-person (Group) Mumbai Click here *The above schedule is subject to change due to exigencies, if any. The Company will be represented by its senior management, along with members of the leadership team of Armed Cell Therapeutics (ACTx). You are requested to take the above information on record and disseminate the same on your respective websites. The above information is also available on the website of the Company at www.mankindpharma.com. For further information, please contact: Mankind Pharma Limited – Investor Relations Archit Gupta Email: investor.relations@mankindpharma.com M: +91 97900 90279 Adfactors PR-Investor Relations: Smit Shah Forum Goshar Email: smit.shah@adfactorspr.com Email: forum.goshar@adfactorspr.com M: +91 98707 89596 M: + 91 70456 46599 Thanking you Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer